Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE

被引:16
|
作者
Branche, Brandee L. [1 ]
Howard, Lauren E. [1 ,2 ]
Moreira, Daniel M. [3 ]
Roehrborn, Claus [4 ]
Castro-Santamaria, Ramiro [5 ]
Andriole, Gerald L. [6 ]
Hopp, Martin L.
Freedland, Stephen J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[3] Univ Illinois, Chicago, IL USA
[4] Univ Texas Southwestern, Med Ctr, Dallas, TX USA
[5] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc R&D Unit, King Of Prussia, PA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cedars Sinai Med Ctr, 8635 West 3rd St,Suite 1070W, Los Angeles, CA 90048 USA
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 02期
基金
美国国家卫生研究院;
关键词
prostate; prostatic hyperplasia; lower urinary tract symptoms; sleep; patient reported outcome measures; PROSTATE-CANCER EVENTS; OBESITY; TRIAL; DUTASTERIDE; METABOLISM; NOCTURIA; SCALE; TIME; RISK; MEN;
D O I
10.1016/j.juro.2017.08.108
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although lower urinary tract symptoms and sleep problems often develop together, to our knowledge it is unknown whether sleep disturbances are linked to lower urinary tract symptoms development and progression. As measured by the 6-item MOS-Sleep (Medical Outcomes Study Sleep Scale) survey we examined the relationship between sleep problems, and the development and progression of lower urinary tract symptoms in the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) study. Materials and Methods: REDUCE was a randomized trial testing prostate cancer chemoprevention with dutasteride in men with prostate specific antigen 2.5 to 10 ng/ml and a negative biopsy. At baseline men completed MOS-Sleep and a scaled average was used to calculate the sleep score. Men were followed for 4 years and I-PSS (International Prostate Symptom Score) was completed at baseline and every 6 months. Asymptomatic men had I-PSS less than 8 while symptomatic men had I-PSS 8 or greater. In the placebo arm of 2,588 men not receiving a-blockers or 5a-reductase inhibitors at baseline we tested the association between sleep problems and lower urinary tract symptom development and progression using Cox models. Results: During followup lower urinary tract symptoms developed in 209 of 1,452 asymptomatic men (14%) and 580 of 1,136 (51%) with lower urinary tract symptoms demonstrated progression. On multivariable analysis higher sleep scores were suggestively associated with increased lower urinary tract symptoms in asymptomatic men (quartile 4 vs 1 HR 1.41, 95% CI 0.92-2.17, p = 0.12) and with lower urinary tract symptom progression in symptomatic men (per 10 points of sleep score HR 1.06, 95% CI 1.01-1.12, p = 0.029). Conclusions: Among men with lower urinary tract symptoms worse sleep scores were associated with the progression of lower urinary tract symptoms and among asymptomatic men worse sleep scores were suggestively associated with the development of lower urinary tract symptoms. If confirmed, these data suggest that sleep problems may precede such symptoms. Whether treating sleep problems would improve lower urinary tract symptoms requires further testing.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [31] Patient Characteristics Associated with More Bother from Lower Urinary Tract Symptoms
    Liu, Alice B.
    Liu, Qian
    Yang, Claire C.
    Griffith, James W.
    Smith, Abigail R.
    Helmuth, Margaret E.
    Lai, H. Henry
    Amundsen, Cindy L.
    Erickson, Bradley A.
    Jelovsek, J. Eric
    Agochukwu, Nnenaya Q.
    Mueller, Margaret G.
    Andreev, Victor P.
    Weinfurt, Kevin P.
    Kenton, Kimberly S.
    Fraser, Matthew O.
    Cameron, Anne P.
    Kirkali, Ziya
    Gore, John L.
    JOURNAL OF UROLOGY, 2019, 202 (03): : 586 - 592
  • [32] Re: Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 199 (02): : 322 - 323
  • [33] Lower Urinary Tract Symptoms
    Gammack, Julie K.
    CLINICS IN GERIATRIC MEDICINE, 2010, 26 (02) : 249 - +
  • [34] A Prospective Study of Obesity, and the Incidence and Progression of Lower Urinary Tract Symptoms
    Mondul, Alison M.
    Giovannucci, Edward
    Platz, Elizabeth A.
    JOURNAL OF UROLOGY, 2014, 191 (03): : 715 - 721
  • [35] Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study
    Fukunaga, Arinobu
    Kawaguchi, Takahisa
    Funada, Satoshi
    Yoshino, Takayuki
    Tabara, Yasuharu
    Matsuda, Fumihiko
    Yoshimura, Koji
    Ogawa, Osamu
    Negoro, Hiromitsu
    JOURNAL OF UROLOGY, 2019, 202 (02): : 354 - 360
  • [36] Female sexual dysfunction and lower urinary tract symptoms associated with vulvovaginal atrophy symptoms: Results of the GENJA study
    Ozaki, Yumi
    Tomoe, Hikaru
    Shimomura, Mayuka
    Ninomiya, Noriko
    Sekiguchi, Yuki
    Sato, Yoshikazu
    Nagao, Koichi
    Takahashi, Yoshimitsu
    Takahashi, Satoru
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (10) : 860 - 865
  • [37] BLADDER CANCER IS NOT ASSOCIATED WITH IRRITATIVE LOWER URINARY TRACT SYMPTOMS
    Idriz, S.
    Gao, H.
    Malone-Lee, M.
    Lunawat, R.
    Khan, S.
    Khasriya, R.
    Malone-Lee, J.
    Bishara, S.
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (07) : 758 - 759
  • [38] Suspected Ketamine-Associated Lower Urinary Tract Symptoms
    Peng, Tzu-Rong
    Lee, Ming-Chia
    Wu, Ta-Wei
    Lan, Chou-Chin
    UROLOGY JOURNAL, 2014, 11 (02) : 1508 - 1510
  • [39] Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study
    Feng, Tom
    Howard, Lauren E.
    Vidal, Adriana C.
    Moreira, Daniel M.
    Castro-Santamaria, Ramiro
    Andriole, Gerald L.
    Freedland, Stephen J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (02) : 151 - 156
  • [40] Re: Prostatic Fibrosis is Associated with Lower Urinary Tract Symptoms
    Shah, Sharad R.
    JOURNAL OF UROLOGY, 2013, 189 (05): : 2000 - 2001